ArticleCancers2025

Comparing the Prognostic Value of Quantitative Response Assessment Tools and LIRADS Treatment Response Algorithm in Patients with Hepatocellular Carcinoma Following Interstitial High-Dose-Rate Brachytherapy and Conventional Transarterial Chemoembolization.

Robin Schmidt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.